Upstream Partners


Upstream News

IAM Strategy 300 for 2018

Mark Chandler was again recognized by Intellectual Asset Magazine as one of the World’s Leading IP Strategists, by being included in the IAM 300 for the tenth straight year. This peer-selected list cites individuals whose key skill-set is working with IP owners to help them maximize the value of their patents, copyrights, trademarks and other rights.

Click here to see the article.

Evolution Optiks

Evolution Optiks has been recognized by the Founders Forum as one of twenty "disruptive tech companies" in North America. 

"Given our teams stealthy creation of technology over the last 5 1/2 years, the company has now been recognized and chosen as 1 of 20 key "disruptive tech companies" in North America." Chris Hough, CEO and Founder of Evolution Optiks presented at the Founders Forum event in NYC, revealing the company's game-changing platform.

Evolution Optiks is creating the first real seamless solution for Presbyopia (Farsightedness) and removing the need for corrective lenses when using mobile phone screens. The company is venture backed and has developed a personalized visual acuity solution for viewers of mobile devices and automotive display screens.

Click here to see the article.

WARF v Apple infringement damages increased

Apple ordered to pay $506 million to university in patent dispute.

In late July, 2017, A U.S. judge ordered Apple Inc to pay $506 million for infringing on a patent owned by the the Wisconsin Alumni Research Foundation, University of Wisconsin-Madison's patent licensing arm, more than doubling the damages initially imposed on Apple by a jury.

U.S. District Judge William Conley in Madison added $272 million to a $234 million jury verdict the Wisconsin Alumni Research Foundation won against Apple in October 2015. Conley said WARF is owed additional damages plus interest because Apple continued to infringe the patent, which relates to computer processor technology, until it expired in December 2016. Mark Chandler testified on licensing and damages on behalf of WARF in the U.S. District Court trial.

Click here to view the article.

Children's Hospital spinoff

Upstream assists Children's National Medical Center in Robotic Surgery venture

Upstream Partners helped negotiate a license and structure a transaction that provided Omniboros, Inc. a robotic surgery company spun out of Children's National Health System. Omniboros raised $1.5 million in funding from Great Point Ventures, a SIlicaon Valley-based venture capital firm. with a license to a large patent portfolio and additional know-how.

The technology in known as the Smart Tissue Autonomous Robot, or STAR, has demonstrated the ability to conduct autonomous soft tissue surgery with a robotic device. The device has been shown to able to suture live pigs and inanimate pig tissue with more precision than a human hand. Omniboros, based in Washington, DC., will be continuing in vivo testing throughout 2017 and 2018.

Click here to view the article.